Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01692561 · ClinicalTrials.gov registry record

MRI to Assess the Effects of Dysautonomia and Chronic Nausea on Brain Transmitters

A clinical trial, sponsored by Wake Forest University Health Sciences.

Completed
Registry status
22
Enrollment target

NCT01692561 is a clinical trial that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 22 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01692561 has completed, sponsored by Wake Forest University Health Sciences.

COMPLETED
Registry status
22 participants
Enrollment target

Study Summary

The purpose of this research study is to better understand what causes dysautonomia and how this affects blood pressure and pulse. Dysautonomia is a condition of the autonomic nervous system. It is associated with fluctuations in blood pressure and pulse and may cause symptoms of nausea and belly pain, fatigue, excessive thirst, lightheadedness, dizziness, feelings of anxiety or panic, and fainting. A common example of dysautonomia is postural orthostatic tachycardia syndrome or POTS. Sometimes symptoms worsen when people move from lying down to standing, called orthostatic intolerance. We would like to learn more about the link between orthostatic intolerance and nausea. While medications currently used to treat orthostatic intolerance and nausea have proven to be effective in some patients, this may not be the best treatment for everyone as long term use could pose certain risks including high blood pressure. In order to provide a more focused and safer treatment for patients suffering from nausea and orthostatic intolerance, we have looked at how the blood pressure, pulse, and certain blood tests change during a tilt table test. This test helps to create the same circumstances that patients with orthostatic intolerance experience when they stand. To better understand if some of these problems are associated with the brain, we will study MRI in patients with dysautonomia compared to children without dysautonomia. This information may allow us to use alternative and safer treatments in the future.

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2012-08
Est. Completion 2013-06-11

Sponsor

Wake Forest University Health Sciences

1,140 total trials

What the Registry Record Tells You About NCT01692561

The ClinicalTrials.gov registry entry for NCT01692561 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01692561 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01692561 about?

NCT01692561 is a clinical study titled "MRI to Assess the Effects of Dysautonomia and Chronic Nausea on Brain Transmitters". The purpose of this research study is to better understand what causes dysautonomia and how this affects blood pressure and pulse. Dysautonomia is a condition of the autonomic nervous system. It is associated with fluctuations in blood pressure and pulse and may cause symptoms of nausea and belly pa...

What is the current status of trial NCT01692561?

This trial is currently completed. The enrollment target is 22 participants. The study started on 2012-08. Estimated completion is 2013-06-11.

Who is sponsoring clinical trial NCT01692561?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.